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AbstractIn the present study, a simple, inexpensive, precise and accurate UV-spectrophotometric method based on chemometrics, has been developed for the simultaneous determination of sulfadoxine and pyrimethamine in tablet formulation. The % recoveries obtained were 99.7% ± 0.9% and 101.5% ± 0.8% for sulfadoxine and pyrimethamine, respectively. The developed method has been compared to USP-HPLC method with regard to accuracy and precision. The calculated F-ratio 
and the (t) statistics indicate that there is no significant difference at 5% level with regard to precision and accuracy between the proposed and the USP methods. Moreover, the developed method is simple, cost-effective, and less time-consuming. Accordingly, it can be used advantageously in routine quality control of sulfadoxine and pyrimethamine in tablet formulation.
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Malaria, caused by plasmodium parasite, is the number 
one killer disease in many developing countries. It is 
endemic in tropical countries in Africa, Asia, and South 
America. The disease has an economic and social impact 
on the communities and its treatment is a priority. The 
natural alkaloid, quinine, extracted from Cinchona bark, 
was the first anti-malarial drug. In the present time, 
several synthetic anti-malarial drugs such as chloroquine, 
balaquine, mefloquine, mepacrine, and proguanil are 
administered separately or combined. By time the malarial 
parasite developed resistance rendering the majority of 
the synthetic anti-malarials in-effective. The search for a 
radical treatment of malaria is relentless and attempts to 
prepare vaccine were reported1.
Sulfadoxine (Figure 1), is chemically known as 
4-amino-N- (5, 6-dimethoxy-4-pyrimidinyl) benzene 
sulfonamide. It is approved by the United States Food and 
Drug Administration for use as treatment and preventive 
measure against malaria2. It is an ultra-long-lasting 
sulfonamide often combined with pyrimethamine to treat 
or prevent malaria. However, due to its side effects, it is no 
longer recommended as a routine preventive measure3, 
but only to treat serious malarial infections or to prevent 
them in areas where other drugs may not work4.
Figure 1.    Molecular structure of Sulfadoxine.
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Pyrimethamine (Figure 2) is known chemically as 
5-(4-chlorophenyl)-6-ethyl-2,4-pyrimidine diamine. 
It is a medication used for protozoal infections and 
administered as an anti-malarial drug (4).
Figure 2.    Molecular structure of Pyrimethamine.
Sulfadoxine and pyrimethamine combination is used 
in the treatment of acute, uncomplicated Plasmodium 
falcipram malaria for patients in whom chloroquine 
resistance is suspected. In addition, the combination 
may be recommended as a prophylaxis for travellers to 
areas where chloroquine resistant P. falcipram malaria 
is endemic or when alternative therapy is not available 
or is contraindicated. Under certain circumstances, the 
combination may also be used in toxoplasmosis cases5.
Sulfadoxine-pyrimethamine combination induces 
serious side effects including fever, increased sensitivity of 
skin to sunlight, soreness of the tongue and skin rashes3. 
Less common side effects are blood in urine or stool, chest 
pain, cough, loss of appetite, nausea, painful and difficult 
urination, yellow eyes and skin, and weakness3. Overdose 
causes severe bleeding and bruising, unsteadiness, and 
convulsion3.
To achieve desirable curative effect and lower 
toxicity, quality control of the content of each drug in 
the tablet formulation is crucial. Various UV, HPLC, and 
electrophoretic quantitative methods6–13 were reported 
for the estimation of sulfadoxine and pyrimethamine 
separately and combined with other drugs. The United 
States Pharmacopoeia (USP) adopts Reverse Phase 
High Performance Chromatography (RP-HPLC) for the 
simultaneous assay of sulfadoxine and pyrimethamine in 
tablets14. 
In this connection, it can be seen that within 
the last decade or so a number of publications have 
emerged in the literature dealing with the applications 
of UV-chemometric techniques15,16 to the simultaneous 
determination of individual drugs coexisting in mixtures. 
These techniques have now gained recognition in the 
quality control of drug mixture and pharmaceutical 
formulations containing two or more active ingredients 
with overlapping spectra without prior separation. In17–21 
is indicated as notable examples.
In this work, a simple, accurate, precise, and 
inexpensive quantitative method has been developed 
for the simultaneous determination of the coexisting 
two drugs in tablet dosage form. The method is based 
on a chemometric procedure involving the inverse UV-
calibration method without prior separation. Compared 
to HPLC, the developed chemometric UV-procedure 
proved to be adequately accurate and precise. Moreover, 
being simple and inexpensive, it is more appealing to 
use for routine assay of sulfadoxine-pyrimethamine 
combination in tablet than HPLC which is demanding in 
terms of running cost and sophistication.
2.  Experimental
2.1 Theoretical Considerations
Binary mixtures of drugs with overlapping UV-spectra 
may be determined by zero order spectrophotometry 
when the overlapping does not obscure the existence of 
two distinctly separate absorption maxima. However, 
in case of substantial spectral overlapping, derivative 
UV-spectrophotmetry may be adopted successfully for 
the simultaneous analysis of the two components of the 
mixture. Furthermore, the spectral overlapping may be 
so severe such that derivative spectrophotometry is not 
capable to resolve the problem. In such situations, HPLC 
is the method of choice since this technique possesses the 
ability to separate the components and quantify each.
It is of interest to apply the inverse calibration method 
using UV-spectrophotometry for the simultaneous 
determination of sulfadoxine and pyrimethamine 
in tablet dosage form. The success of the attempt is 
rewarding as it means that a simple, inexpensive, and 
reliable UV-spectrophotometric method can be used 
for the simultaneous determination of sulfadoxine and 
pyrimethamine in tablet formulation.
The theoretical basis of the inverse calibration 
procedure9 originated in equation (1).
C = f (A)     (1)
where concentration, is a function of absorbance, 
A. This is the inverse of classical method where (A) is a 
Vol 8 (3) | 2016 | www.informaticsjournals.com/index.php/ajprhc Asian Journal of Pharmaceutical Research and Health Care78
A UV-Spectrophotmetric Chemometric Method for the Simultaneous Determination of Sulfadoxine and Pyrimethamine in 
Tablets
function of (C). For the binary mixture, two concentration 
variables are involved, namely, C1 and C2.
Generally the inverse calibration method can be 
implemented for a binary mixture as follows:
•	 Initially the UV-spectrum of each component is 
recorded and at least 5 wavelengths (λ1, λ2, λ3, λ4, 
λ5) selected in the overlapping zone for measuring 
absorbance, A1, A2, A3, A4, and A5.
•	 About seven standard solutions are prepared 
containing known varying concentrations (C1 and C2) 
of the pure components. The number of wavelengths 
selected should be greater than the number of 
components.
•	 The absorbance of each of the above solutions 
in (ii) is measured at λ1, λ2, λ3, λ4, and λ5 to give 
correspondingly A1, A2, A3, A4, and A5.
•	 The data of (iii) are processed by suitable software 
program such as Minitab 14 to give two calibration 
equations. The calibration equations (2 and 3) are 
worked out by multiple linear regressions based on 
the principles of least-squares.
C1 = k1+α1A1+ α2A2+ α3A3+ α4A4+ α5A5   (2)
C2 = k2 + β1 A1+ β2 A2+ β3 A3+ β4 A4+ β5 A5  (3)
C1 and C2 are concentrations of the components of 
the binary mixture, k1 and k2 are constants, αi and βi are 
coefficients. The constants and coefficients are worked out 
by the software program used.
•	 Similarly, solutions of the samples are treated by 
measuring absorbances, A1, A2, A3, A4, and A5 at the 
corresponding wavelengths λ1, λ2, λ3, λ4, and λ5.
•	 The measured absorbances of the samples are 
substituted in the calibration equations (2 and 3) to 
give C1 and C2.
•	 The content of each component in the tablet 
formulation is computed using C1 and C2. 
2.2 Materials
Sulfadoxine reference substance was obtained from 
Control of Pharmaceutical and Biological Products, Beijin, 
China. Pyrimethamine reference standard was purchased 
from Lupin Pharmaceuticals, India. The pharmaceutical 
formulation of tablets containing sulfadoxine-
pyrimethamine was a gift from Amipharma, Khartoum, 
North Sudan. Phenacitin donated by Khartoum Medical 
Supplies, Sudan was used as internal standard. 
2.3 Solvents
HPLC grade methanol, and distilled water. Acetonitrile 
was obtained from Scharalau Chemie, Spain. Glacial 
acetic acid was analytical grade reagent obtained from 
Guangzhou Chemicals Reagent Factory, Guangzhou, 
China.
2.4 Instrumentation
Schimadzu Groups UV-Vis-Spectrophotometer 
model Mini 1240, made in Japan, was used in the 
spectrophotometric measurements.
For chromatography, Schimadzu High Performance 
Liquid Chromatograph, model Sol-10 AVP with a Variable 
UV-detector, made in Japan, and was used at ambient 
temperature. Stainless steel C18 column containing 
packing L1 and of dimensions 30 cm x 3.9 mm (I.D.) was 
employed.
2.5  UV-Spectra and the Calibration 
Equations
About 0.5 g of sulfadoxine reference standard was 
accurately weighed and dissolved in 100 mL methanol. 
Similarly, a stock solution was prepared by dissolving 
about 0.025 g of pyrimethamine, accurately weighed, 
in 100 mL methanol. Separate dilute solutions were 
prepared from the stock solution for each drug and a 
binary mixture. The UV-spectra were recorded in the 
range 200-400 nm as shown in Figures (3 to 5).
2.6 The Calibration Equations
To obtain the two calibration equations, five wavelengths 
in the overlapping zones, namely, 291, 286, 276, 273, 
and 268 nm were selected for measurement of the 
absorbance A1, A2, A3, A4, and A5 of the binary mixtures 
containing known varying concentrations of sulfadoxine 
and pyrimethamine. Absorbances of seven mixtures are 
assembled in Table 1.
The application of Minitab 14 software using the data 
in Table 1 gave the following calibration equations.
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C1 = 1.47 + 42.4A1 + 21A2 – 15A3 - 316A4 + 318A5  
      (4)
R2 = 99.9%
C2 = 0.07 + 2.12A1 + 1.0A2 - 0.77A3 - 15.8A4 + 15.9A5  
       (5)
R2 = 99.9%
where C1 and C2 stand for the concentrations of 
sulfadoxine and pyrimethamine, respectively.
2.7  Checking the Reliability of the 
Calibration Equations
A series of synthetic binary mixtures of sulfadoxine 
and pyrimethamine reference standards were prepared 
and the amount of each recovered was found from the 
calibration equations (2 and 3) using A1, A2, A3, A4, and 
A5 absorbance (Table 2).
2.8 Sample Preparations and Procedures
Twenty tablets were weighed, powdered in a mortar, and 
the average weight of tablet was calculated. An amount of 
powder equivalent to one tablet was accurately weighed, 
transferred to a volumetric flask and dissolved in 100 
mL methanol by mechanical stirring for 30 minutes. The 
mixture was filtered, and the filtrate was kept as a stock 
solution from which suitable dilutions were prepared to 
give absorbance A1, A2, A3, A4, and A5 at the corresponding 
wavelengths, λ1, λ2, λ3, λ4, and λ5. Table 3 shows the % 
recoveries of sulfadoxine and pyrimethamine in the tablet 
formulation.
2.9 The USP HPLC Method
2.9.1 Mobile Phase
Prepared by degassing and filtering a mixture of dilute 
glacial acetic acid (1 in 100) and acetonitrile (1:4 v/v).
2.9.2 Stock Solution
About 500 mg of standard sulfadoxine and 25 mg of 
standard pyrimethamine were accurately weighed, 
transferred to 100 mL volumetric flask and dissolved in 
about 35 mL acetonitrile. The volume was adjusted to 100 
mL with the mobile phase.
2.9.3 Standard Preparation 1
Exactly 25 mL of the stock solution and 2 mL of the 
internal standard solution were transferred to 50 mL 
volumetric flask, adjusted to volume with the mobile 
phase and mixed.
2.9.4 Standard Preparation 2
Exactly 2 mL of the stock solution and 10 mL of the 
internal standard solution were transferred to 250 mL 
volumetric flask, adjusted to volume with the mobile 
phase and mixed.
2.9.5 Assay Preparations
From the remaining powder of the 20 tablets ground in the 
spectrophotometric part of this work, a sample equivalent 
to 500 mg sulfadoxine and 25 mg pyrimethamine 
was accurately weighed and transferred into 100 mL 
volumetric flask. About 35 mL of the acetonitrile was 
added, and the mixture was shaken for 30 minutes. The 
volume was adjusted to 100 mL with the mobile phase 
mixed, and filtered through 0.45 μm membrane filter. 
Exactly 25 mL of the filtrate and 2 mL of the internal 
standard solution were transferred to 50 mL volumetric 
flask, adjusted to volume with the mobile phase and 
mixed to give assay preparation 1.
For assay preparation 2, 10 mL of the internal standard 
solution and 2 mL of the filterate were transferred into 250 
mL volumetric flask, diluted to volume with the mobile 
phase and mixed.
2.10   The Chromatographic System 
Optimization
Five 10 μL aliquots of the standard preparation and 
assay preparation were separately injected and the peak 
responses were recorded at 2 mL/minute flow rate. 
The relative standard deviation was less than 2.5%, the 
resolution factor between the internal standard and 
sulfadoxine on one hand and pyrimethamine on the 
other hand was not less than 1.0. No interfering peaks by 
excipients of the formulation were observed (Figure 6).
2.11 Procedure
Equal volumes of 10 μL of the standard preparation 
and assay preparation were separately injected into the 
chromatograph. From the peak responses obtained, the 
quantity (in mg) of sulfadoxine in the portion of tablet 
taken was calculated by the formula:
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12.5 C (Ru/Rs)
where C is the concentration (in μg/mL) of standard 
sulfadoxine in the standard preparation 2, and Ru and Rs 
are the relative peak response ratios obtained from assay 
preparation 2, and the standard preparation, respectively.
Similarly the quantity (in mg) of pyrimethamine in the 
portion of tablets taken was calculated from the formula:
0.2 C (Ru/Rs)
where C is the concentration (in μg/mL) of standard 
pyrimethamine in the standard preparation 1, and Ru and 
Rs are the relative peak response ratios obtained from 
assay preparation 1, and the standard preparation 1, 
respectively.
Table 4 shows the comparison of the results obtained 
by the developed chemometric and the USP-HPLC 
methods. 
3.  Results
A UV-spectrophotmetric chemometric method for 
the simultaneous determination of sulfadoxine and 
pyrimethamine in tablets has been developed. Figure 3 and 
Figure 4 represent the ordinary UV-spectra of methanolic 
solutions of pure sulfadoxine and pyrimethamine with 
absorption maxima at 273 nm and 276 nm, respectively.
Figure 3.    Zero order absorption spectrum of pure 
sulfadoxine (10…).
Figure 4.    Zero order absorption spectrum of pure 
pyrimethamine (1.0 μg/mL in methanol).
On the other hand Figure 5 depicts the UV-absorption 
spectrum of the binary mixture.
Figure 5.    Zero order absorption spectrum of mixture 
of sulfadoxine and pyrimethamine.
The merger of Figure 3 and Figure 4 highlights the 
need for a selective analytical method for the simultaneous 
determination of the two components. The developed 
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chemometric method can be advantageously applied to 
resolve the problem.
Figure 6.    Representative chromatogram of Pyrimethamine 
(a) and Sulfadoxine (b) in the tablet extract in the presence 
of the internal Standard (IS).
Table 1 displays the absorbance values of seven 
synthetic mixtures used for computation of the constants 
and the coefficient of the calibration equations. The value 
of the coefficient of determinations (R2 = 99.9%) suggests 
excellent linearity.
Table 1.    Absorbance values (A1, A2, A3, A4, and A5) 








A291 A286 A276 A273 A268
10.0 0.50 0.382 0.449 0.659 0.667 0.640
9.0 0.45 0.337 0.440 0.580 0.587 0.562
8.0 0.40 0.313 0.408 0.539 0.545 0.521
7.0 0.35 0.270 0.353 0.467 0.472 0.451
6.0 0.30 0.233 0.306 0.404 0.409 0.390
5.0 0.25 0.189 0.248 0.328 0.331 0.315
4.0 0.20 0.149 0.195 0.259 0.262 0.248
The data collected in Table 2 summarize the results 
obtained when checking the validity of the two calibrating 
equations. The % recoveries of 99.7% and 99.4% and the 
RSD% of ±1.5 and ±3.2 reflect satisfactorily valid results.
Table 3 exhibits the % recoveries obtained by applying 
the developed chemometric method to the simultaneous 
determination of sulfadoxine and pyrimethamine in 
tablet dosage form. The mean % recoveries were 99.7% 
Table 2.    Simultaneous determination of sulfadoxine and pyrimethamine in the binary synthetic mixtures using 










10.0 9.96 99.6 0.50 0.51 102.0
9.0 8.86 98.4 0.45 0.46 102.2
8.0 7.86 98.3 0.40 0.39 97.5
7.0 6.86 98.0 0.35 0.36 102.9
6.0 6.06 101.0 0.30 0.30 100
5.0 5.06 101.2 0.25 0.24 96
4.0 4.06 101.5 0.20 0.19 95
Mean % recovery = 99.7 
RSD% = ±1.5
Mean % recovery = 99.4  
RSD% = ±3.2











10 9.97 99.7 0.50 0.52 104.0
9 8.97 99.7 0.45 0.44 97.8
8 7.87 98.4 0.40 0.39 97.5
7 6.97 99.6 0.35 0.36 102.9
6 5.98 99.7 0.30 0.31 103.3
5 5.06 101.2 0.25 0.25 100
4 3.97 99.3 0.20 0.21 105.0
Mean % recovery = 99.7  
RSD % = ±0.9
Mean % recovery = 101.5  
RSD % = ±0.8
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and 101.5% with the corresponding % RSD of ±0.9 and 
±0.8 for sulfadoxime and pyrimethamine, respectively.
The results assembled in Table 4 show the comparison 
of the developed chemometric and USP methods 
regarding accuracy and precision. The calculated t (tcal) 
and the Eratio (Fcal) at 5% level of significance are greater 
than the tabulated counter parts suggesting insignificant 
differences between the developed and the USP method.
4.  Discussion
The UV-Spectra, Figure 3 to 5, of sulfadoxine and 
pyrimethamine exhibit severe overlapping with the 
absorption maxima too close, namely, 273 nm and 276 
nm. Under such circumstances ordinary and derivative 
spectrophotometric methods are not recommended for 
simultaneous determination of the two drugs since their 
spectra are irresolvable.
In such severe spectral overlapping, the inverse 
calibration method can be advantageously applied for the 
simultaneous determination of the two components. 
Accordingly, absorbance of binary synthetic mixture 
of known varying concentration was measured for each 
mixture at the five selected wavelengths in the domain 
of spectral overlapping. Multiple linear regressions using 
Minitab 14 gave two calibration equations (4 and 5).
C1 = 1.47 + 42.4A1 + 21A2 – 15A3 - 316A4 + 318A5  
       (4)
R2 = 99.9%
C2 = 0.07 + 2.12A1 + 1.0A2 - 0.77A3 - 15.8A4 + 15.9A5  
       (5)
R2 = 99.9%
where C1 and C2 stand for concentration (in μg/mL) 
of sulfadoxine and pyrimethamine, respectively, and Ai 
are the absorbances of the binary mixtures at the selected 
wavelengths. The coefficient of determination, R2, 
indicated excellent linearity. The results of the % recovery 
in Table 2 proved the validity of the two calibration 
equations (4 and 5).
When the procedure was applied for the simultaneous 
assay of sulfadoxine and pyrimethamine in tablet 
dosage form, adequate % recoveries were obtained 
as shown in Table 3. Comparison of the results of the 
assay by employing the USP-HPLC and the developed 
Chemometric method was encouraging using the t-test 
for accuracy and the F-ratio test for precision.
5.   Conclusion and 
Recommendation
A simple UV-spectrophotometric method based on 
chemometrics was developed for the simultaneous 
determination of sulfadoxine and pyrimethamine in 
tablet formulation. The proposed method succeeded 
in obtaining satisfactory % recoveries and standard 
deviation, namely, 99.7 ± 0.9 and 101.5 ± 0.8, for 
sulfadoxine and pyrimethamine, respectively. Statistical 
comparison of the recovery results by the developed 
method with those of the USP-HPLC method using the 
t-test and F-ratio showed no significant difference at 5% 
level with regard to accuracy and precision. In addition, 
the developed method requires no prior separation for 
the determination of each of the two- co-existing drugs. 
It is to be noted that the tolerance range indicated by USP 
for the combined sulfadoxine and pyrimethamine is 90% 
Table 4.    Results of assay by the developed chemometric UV-Spectrophotometric and the USP-HPLC methods
Developed Chemometric Method Developed Chemometric Method
(Sulfadoxine) (Pyrimethamine)
Claimed/Tablet *Found (mg) Claimed/Tablet *Found (mg)
500 mg 498.9 ± 1.1 25 mg 24.8 ± 1.4
USP-HPLC Method USP-HPLC Method
(Sulfadoxine) (Pyrimethamine)
Claimed/Tablet *Found (mg) Claimed/Tablet *Found (mg)
500 mg 499.4 ± 0.8 25 mg 25.2 ± 1.1
tcal = 2.01 tcrit = 2.23 (α = 0.05) tcal = 1.23 tcrit = 2.23 (α = 0.05)
Fcal = 1.89 Fcrit = 5.05  
df1= df2 = 5 (α = 0.05)
Fcal = 1.62 Fcrit = 5.05  
df1= df2 = 5 (α = 0.05)
*n = 6
Vol 8 (3) | 2016 | www.informaticsjournals.com/index.php/ajprhc Asian Journal of Pharmaceutical Research and Health Care 83
Hagga M. A. Mohamed, Mohd. Imran, Monadil H. M. Ali, Mohammed F. Abdelwahab and Abdullrahman A. Alhaj
to 110% in tablet formulation. As such the method is cost-
effective and can be used as a routine in the quality control 
of the combination of sulfadoxine and pyrimethamine in 
tablet formulation.
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